We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

67 hedge funds and large institutions have $29.1M invested in Genesis Healthcare, Inc. in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

3% less funds holding

Funds holding: 6967 (-2)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

49% less capital invested

Capital invested by funds: $57.6M → $29.1M (-$28.5M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
67
Holders Change
-2
Holders Change %
-2.9%
% of All Funds
1.48%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
9
Increased
21
Reduced
19
Closed
10
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
-$7K
Name Holding Trade Value Shares
Change
Change in
Stake
VCM
1
V3 Capital Management
Texas
$4.32M
BlackRock
2
BlackRock
New York
$3.81M -$136K -95,010 -2%
Renaissance Technologies
3
Renaissance Technologies
New York
$3.65M +$243K +169,988 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.2M +$1.14M +799,522 +27%
FWC
5
First Washington Corp
Washington
$3.03M -$848K -593,239 -14%
Chevy Chase Trust
6
Chevy Chase Trust
Maryland
$2.21M
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$1.37M +$21K +14,732 +0.9%
State Street
8
State Street
Massachusetts
$1.09M +$125K +87,742 +7%
Northern Trust
9
Northern Trust
Illinois
$900K +$127K +88,773 +9%
PAM
10
Panagora Asset Management
Massachusetts
$696K -$220K -153,847 -16%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$667K +$149K +104,269 +15%
Millennium Management
12
Millennium Management
New York
$656K -$164K -114,786 -13%
BCM
13
Bridgeway Capital Management
Texas
$501K -$341K -238,800 -29%
N
14
Nuveen
North Carolina
$486K -$67K -46,918 -8%
JP Morgan Chase
15
JP Morgan Chase
New York
$265K -$106K -73,922 -19%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$186K
Charles Schwab
17
Charles Schwab
California
$177K +$7.08K +4,952 +2%
Connor, Clark & Lunn Investment Management (CC&L)
18
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$167K +$36.6K +25,586 +15%
DWT
19
Dorsey & Whitney Trust
South Dakota
$161K
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$146K -$56.9K -39,800 -19%
Wells Fargo
21
Wells Fargo
California
$129K +$22.4K +15,674 +11%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$109K +$2.13K +1,491 +1%
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$96K
AllianceBernstein
24
AllianceBernstein
Tennessee
$90K +$7.57K +5,300 +5%
AWW
25
Alan W. Weber
$84K

GEN Hedge Fund Activity: Q1 2020 in Review

67 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2020, worth a combined $29.1M — down 49% from $57.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GEN and 9 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 21 added.

The largest buyer was Vanguard Group, adding an estimated $1.14M. The largest seller was First Washington Corp, cutting an estimated $848K.

  • 67 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2020, down from 69 in Q4 2019.
  • Funds reported $29.1M of Genesis Healthcare, Inc. stock for Q1 2020, down 49% quarter-over-quarter.
  • 9 funds opened new Genesis Healthcare, Inc. positions in Q1 2020 and 10 closed out, a net change of -1 holder.
  • The largest Genesis Healthcare, Inc. buyer in Q1 2020 was Vanguard Group, an estimated $1.14M added.
  • The largest Genesis Healthcare, Inc. seller in Q1 2020 was First Washington Corp, an estimated $848K sold.

Based on aggregated 13F filings for Q1 2020.